Regulatory Spine BioRestorative Therapies Announces FDA Clearance of Phase 2 BRTX-100 Clinical Study Protocol Amendment byTim AllenApril 16, 2024
Hospitals Histogenics Corporation Announces Amendment to NeoCart® Phase 3 Clinical Trial Enrollment Criteria byJosh SandbergDecember 22, 2015
